A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.
Canada begins its search for a chief government science advisor, Nature News reports.
After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.
In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
The US House of Representatives has passed the latest version of the 21st Century Cures Act.
Mitochondrial replacement therapy may soon be occurring in the UK, according to the Guardian.
The Financial Times looks into how sequencing is moving into the clinic.
In Nature this week: epigenetic contributors to type 1 diabetes, assembly algorithm to detect structural variations, and more.
Nature News looks into health secretary pick Tom Price's views on research funding.
Investors in Theranos may lose out and some are filing lawsuits, the Wall Street Journal reports.
In Genome Biology this week: variants linked to disorders of sex development, new candidate genes for ciliopathies, and more.
After two months in limbo, a shipment of transgenic mice hops a military flight to the Canary Islands, ScienceInsider reports.
President-elect Donald Trump has chosen Rep. Tom Price to lead the Department of Health and Human Services, the New York Times reports.
The US 21st Century Cures Act is set to go up for a vote, though still with some points of contention.
NPR reports that patients have ever-larger sway on medical research, but some are concerned about commercial influences.
In PNAS this week: transcriptional control enables malaria parasite to get around disease control efforts, DNA methylation patterns in the Norway spruce, and more.
The Ottawa Citizen got a fake paper published in its test of quality control at two Canadian publishers recently bought by OMICS International.
A trio of editors from the Nature family of journals describes what make a peer review a good one.
Spots in genetic counseling training programs are competitive, Maclean's reports.
Bitesize Bio offers some tips to make PubMed searches more efficient.
Regeneron Pharmaceuticals comes out on top of Science Careers' ranking of best biotech and pharma employers.